chrisvoncsefalvay/vaers-outcomes huggingface dataset:
72 hrs after injection...unbearable pain from sight to the top of the shoulder similar to rotator cuff pain. it eased up with continuous throbbing. Then 72 hrs later on Jan.14 same extreme pain as if I had rotator cuff surgery without anesthesia, Then the rest of the days continual throbbing especially in the shoulder area. Using Advil and hot compresses. I am limited as to completely using my arm. I have been unable to work at my daily life.
Approximately 12 hrs s/p (L) delt IM admin of MENVEO 0.5cc, pt reported flu-like sx including fevers to 102.2, next night 100.5, chills, sweats, pain to (L) delt with swelling and reported enlarged and tender (L) axillary lymph node "up to size of orange". Sx have mostly resolved. Exam: (L) delt tenderness/firmness, warm site, intact skin; temp 98.4 F.
Employee tested positive for COVID after PCR test given on 8/27/2021.  Test was given after employee had a runny nose.
Intermittent pain in right knee, feels like bee sting since receiving first shot (about a month)
No other AE reported; An expired dose of PROQUAD was administered today; This spontaneous report was received from a physician concerning to a patient of unknown age and gender. The patient concurrent conditions, pertinent medical history, drug allergies/reactions and concomitant medications were not provided.  On 17-MAY-2021, the patient was vaccinated with an expired dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (rHA) (PROQUAD) 1 injection (dosage regimen, route and anatomic site of administration were not provided) as prophylaxis. Lot # S027459 has been verified to be a valid lot number for measles, mumps, rubella and varicella (oka-merck) virus vaccine live, expiration date reported as 21-MAR-2021, but upon internal validation established as 02-MAR-2021.  It was also confirmed that there was no temperature excursion with the administered dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD). No further information was provided, no other adverse event (AE) was reported.
my right foot swelled up and turned bright red. It was incredibly painful. I couldn't walk. It lasted 2 days and then receded. I took 5 Tylenol for the pain in 48 hours.
On 04/01 this infant had a rash all over her body. She had a fever of 101 the day after her vaccination. Her face and neck proceeded to rest of her body, pinkish not in palms. Measle like rash consistent with vaccine.
COVID + on 10/19/2021. Admission Diagnoses: Hypoxemia requiring supplemental oxygen. Pneumonia due to COVID-19 virus.  Patient placed on remdesivir and Decadron.  Symptoms improved and discharged in stable condition.
Person was given 0.3cc dose of Janssen Booster dose instead of standard 0.5 cc. Health authority notified and Manufacturer (Janssen) notified and all persons reported to Janssen Manufacturer for their Pharmacy department, recommendations from the Manufacturer and with agreement from Health authority are to notify all of the recipients that received an incorrect dose and submit an agency report for each.
Vertigo, three episodes in early morning. Then quick episodes of dizziness throughout the day. No further dizziness or vertigo at bedtime nor after that.
Information has been received from a registered nursing referring to a patient of unknown age and gender. There was no pertinent medical history, concomitant medication or drug allergies/drug reactions reported. On 11-NOV-2015, the patient was vaccinated with ZOSTAVAX (0.65 ml, Lot#L024997, expiration date: 06-OCT-2016), which was improperly stored for 49 days (Incorrect product storage). The outcome was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
Information has been received from a physician concerning a 16 week old male patient with no pertinent medical history, no drug reactions or allergies, who on 20-SEP-2010 was vaccinated with a second dose of ROTATEQ (Lot # 663696/0017Y, exp: 31-OCT-2010). There was no concomitant medication. On 22-SEP-2010 the child presented with diarrhea with blood and mucus within the stools. At the time of this report, the patient's adverse event persisted. The patient sought unspecified medical attention. Diarrhea with blood and mucus within the stools was reported by a physician to be an other important medical event. Additional information has been requested.
Big swelling on right arm; Itched like crazy; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Big swelling on right arm) and PRURITUS (Itched like crazy) in a 91-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On an unknown date, the patient experienced PERIPHERAL SWELLING (Big swelling on right arm) and PRURITUS (Itched like crazy).   At the time of the report, PERIPHERAL SWELLING (Big swelling on right arm) and PRURITUS (Itched like crazy) was resolving.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
33 weeks pregnant.  patient claims after vaccination she was bleeding a little from her injection site. she said she is a physician and claims it is unusual to bleed from a vaccine injection.  after telling her it can happen sometimes, she said she felt light headed.  I directed her to sit down for at least 15 minutes to monitor her. I asked her if she would like me to call the emergency number and she agreed. As i was calling emergency number she was helped to the floor by her husband and layed down on her side. She said she was feeling better and requested to cancel EMS. which i did. She said she needed a sugary drink so i  supplied her with orange juice and monitored her for 15 minutes. after the time elapsed she proceeded to walk out of the pharmacy but a minute later she was down on the floor again, claiming she is light headed.  EMS was contacted again and i remained by her side until paramedics arrived
Information has been received from an MD of pharmacy concerning a female pt who was vaccinated wit the 3 dose series of hep B. It was reported that prior to vaccination the pt tested negative for the Hep B core antibody test. Post vax, the pt tested positive for the hep b antibody. Unspecified medical attention was sought. It was reported that the pt did not have nay exposure that she is aware of."  No further information is available.
Reports waking up at 3 AM on 2/9/21 dry heaving, nauseated, extremely weak. Complains of excruciating headaches and pain in the cheek bones. Reports going to the ER on 02/11/2021 due to extreme nausea and headaches. Was prescribed Zofran and given an IV of fluids for being dehydrated.
The patient received a pneumonia vaccine at our pharmacy on 6-30-17. The patient came into our pharmacy late Saturday evening on 7-1-17. Her arm was red  (from below probably where the vaccine was given) to her elbow. It also was swollen and the redness was also coming down her elbow.
Pfizer-BioNtech COVID-19 Vaccine EUA Diarrhea Vomiting Headache Stomach cramps
Information has been received from a 19 year old female who on 18-NOV-2008 was vaccinated with a dose of GARDASIL.  The patient reported that on 20-NOV-2008, "my arm is hurting me at the injection site".  The outcome of the patient was not reported.  She did not seek medical attention.  Additional information has been requested.
Developed shortness of breath a few weeks after receiving his vaccines. Symptoms continue to worsen over the next few months until he presented to the ED on September 6, 2021, when he was diagnosed with extensive bilateral PE's.
Dizziness, Nausea and vomiting for 10-20 minutes. Light headedness for 24 hours.
Patient received second dose too early. Second dose given 1/27 at 11:37 AM  Moderna  Lot # 032L20A. patient reports no adverse effect.
W/in 24hrs of immun mom contacted clinic child refusing to eat-gums red & swollen; DPH given; Seen by MD told rxn was not caused fr HIB;
Gave ped v pt adult dose of HAVRIX. No adverse symptoms, client bigger than nurse.
This case was reported by a pharmacist via call center representative and described the occurrence of rash in a adult female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, 61 days after receiving SHINGRIX, the patient experienced rash, shingles and erythromacular rash. On an unknown date, the outcome of the rash, shingles and erythromacular rash were not recovered/not resolved. The reporter considered the rash, shingles and erythromacular rash to be unrelated to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient developed a rash that the patient considered to be shingles approximately 2 months after a dose of SHINGRIX. The rash consisted of red spots, without blisters in one location, about the size of a half dollar coin. The reporter did not give consent to follow up. The reporter did not consider this to be associated with the dose of SHINGRIX. The reporter was unable to provide specifics of the vaccine or the patient and did not wish to be contacted regarding this case.
Similar to covid infection; Similar to covid infection; Shock sensation on different locations of the body; Could not eat or drink; Feeling weird; Heart beat went up; Tensed; Pink warm face; Flushing of the skin for about 20 mins; Pink warm face/feeling warm; Drank water and then it went away somewhat like after drinking alcohol; Butterflies sensations in the throat; This is a spontaneous report from a contactable consumer. A 29-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: unknown) via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. The patient's medical history included COVID-19 from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: unknown) via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. It was reported that the patient (male, 29 years old) had COVID and then took vaccine and experienced similar side effects like next morning could not eat or drink, feeling weird, heartbeat went up, tensed, pink warm face, flushing of the skin for about 20 mins, feeling warm, drank water and then it went away somewhat like after drinking alcohol. The patient again felt different sensation, butterflies sensations in the throat, heart rate went up, shock sensation on different locations of the body and taking deep breathing. It lasted for about 3-4 days. The outcome of events was recovered/resolved.  Information on the lot/batch number has been requested.
That night I started having chills and couldn't get warm no matter how hard I tried my bones hurt so bad !! I got in hot water and nothing helped  . I started running a fever and it went to 102 F  it was horrible !!! I hurt so very bad all over. I had nausa  and my head would not quit hurting I thought I had a bleed in my brain.!!!! I do'nt know if I should take the next shot or not.??? My arm is swollen and red please let me know
Patient felt faint after the vaccine. Patient felt sweaty, faint, light headed. Patient was helped down to the floor. Patient did not faint. Patient denied any pain. After about 10 minutes he felt better, he was helped into a sitting position and after 10 more minutes helped to a chair. Patients BP was 121/91. He denied any symptoms. Patient left the scene after an additional 15 minutes denying any sympoms.
Pt recvd vax & several hrs p/inject exp vomiting & fever of 102;
Incorrect mRNA COVID-19 vaccine. Product inadvertently administered as a part of a 2- or 3- dose primary series. Client had marked she had Pfizer as #1, but she had Moderna as a first dose.
The patient complained of not feeling well after the injection then fell forward onto the carpeted floor from the chair. patient left arm twitched a a few seconds while on the floor. Patient says he recalled feeling nausea after the shot and only remembers being prone on the floor face down. He does not remember falling forward.
I developed a sore throat, was tested 02/10/2022 and the test was positive.  I had the sore throat, cough, runny nose, fatigue and brain fog for about 10 days.  A rapid test on 02/24/2022 was negative.
Patient came to parent reporting numbness and tingling of legs/feet.  She fell to the ground and begin seizing.  Her aunt, a nurse manager, recognized the symptoms of a seizure and accompanied parent to the ER.  She was transported to another hospital and hospitalized 10/05-10/10/2009.  Patient has continued to have unexplained seizures since that time.  Other symptoms include: low blood pressure, headache, fatigue, hyperventilation, achy and shaky legs. 11/13/09:  Discharge summary and hospital records received for dates of service 10/8/09 to 10/13/09.  Dx:  Psychogenic nonepileptic seizures.  Assessment:  Presented with episodes of lightheadedness, dizziness, near syncopy or syncopy, numbness of legs & feet,  feelings of her lips tingling as well as episodes of hyperventilation.  Eventually sx. increased to loss of awareness and seizure-type activity.  Seen in the ED 3 times in 24 hrs. prior to admission for apparent seizure activity.  Admitted to ICU for observation.  Video EEG noted several events judged nonepileptic in nature.  The apparent seizures were determined to be a conversion disorder.  Pt. discharged to home with instructions to stay home from school, not drive, and to be supervised when bathing.   11/23/09 Hosp. records received for date 10/8/09. DX: Seizure vs pseudoseizure. Presenting SX in ER: active seizure several episodes, upper body shaking, crying. MD witnessed episode, no LOC. Pt. seen in ER 10/7/09 for episodes of hyperventilation.  ICD9 codes: 786.01, 780.39, 782.0
feeling hallucinogenic; dilated pupils; eyelids were hanging; both eyes were red; felt light headed; nausea; feels very tired; This spontaneous case was reported by a consumer and describes the occurrence of HALLUCINATION (feeling hallucinogenic) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Concussion (In 2010, she had a head injury (concussion), and has had two other concussions since then as well.) in 2010. Concurrent medical conditions included Hypersensitivity NOS (sensitive to medications and vaccines).    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, the patient experienced HALLUCINATION (feeling hallucinogenic) (seriousness criterion medically significant), MYDRIASIS (dilated pupils), EYELID PTOSIS (eyelids were hanging), OCULAR HYPERAEMIA (both eyes were red), DIZZINESS (felt light headed), NAUSEA (nausea) and FATIGUE (feels very tired). At the time of the report, HALLUCINATION (feeling hallucinogenic), MYDRIASIS (dilated pupils), EYELID PTOSIS (eyelids were hanging), OCULAR HYPERAEMIA (both eyes were red), DIZZINESS (felt light headed), NAUSEA (nausea) and FATIGUE (feels very tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.  Company comment Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Her face & infusion arm turned red; Felt hot; She saw stars; Her head was just popping; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Her face & infusion arm turned red), FEELING HOT (Felt hot), FEELING ABNORMAL (She saw stars) and HEADACHE (Her head was just popping) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 030A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Nov-2021, the patient experienced ERYTHEMA (Her face & infusion arm turned red), FEELING HOT (Felt hot), FEELING ABNORMAL (She saw stars) and HEADACHE (Her head was just popping). At the time of the report, ERYTHEMA (Her face & infusion arm turned red), FEELING HOT (Felt hot), FEELING ABNORMAL (She saw stars) and HEADACHE (Her head was just popping) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) negative for Covid-19.   No concomitant medications were reported.  No treatment information was provided.  Regeneron IV is a co-suspect but it is not able to code.  It was reported that the patient received a partial dose of the Regeneron IV monoclonal antibodies infusion on Saturday. She only got the infusion for 1 to 2 minutes because as soon as it started she saw stars, felt hot, her face & infusion arm turned red, & her head was just popping.  Company comment- This case concerns a 63 year old female with no reported medical history , who experienced Non-serious , unexpected event of erythema , feeling hot , feeling abnormal and expected event of headache which occurred 7 months and  22 days after vaccination with the 2nd  dose of mRNA-1273 vaccine ( Moderna Covid 19 Vaccine ) . These events were  reported after infusion with monoclonal antibodies ( Regeneron IV infusion ) which the patient took  ( as advised ) ,  when her husband became Covid 19 positive. The re-challenge for this case is not applicable since the outcome of the events  is unknown. The benefit -risk relationship of mRNA -1273 ( Moderna Covid 19 Vaccine) is not affected by this report.; Sender's Comments: This case concerns a 63 year old female with no reported medical history , who experienced Non-serious , unexpected event of erythema , feeling hot , feeling abnormal and expected event of headache which occurred 7 months and  22 days after vaccination with the 2nd  dose of mRNA-1273 vaccine ( Moderna Covid 19 Vaccine ) . These events were  reported after infusion with monoclonal antibodies ( Regeneron IV infusion ) which the patient took  ( as advised ) ,  when her husband became Covid 19 positive. The re-challenge for this case is not applicable since the outcome of the events  is unknown. The benefit -risk relationship of mRNA -1273 ( Moderna Covid 19 Vaccine) is not affected by this report.
This case was reported by a pharmacist via call center representative and described the occurrence of generalized rash in a 80-year-old female patient who received SHINGRIX (batch number B9739, expiry date 20th November 2020) for prophylaxis. On 30th May 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 31st May 2018, 1 days after receiving SHINGRIX, the patient experienced generalized rash. In June 2018, the outcome of the generalized rash was recovered/resolved. It was unknown if the reporter considered the generalized rash to be related to SHINGRIX. Additional details were provided as follows: The patient experienced full body rash and it was resolved after 4 days. The pharmacist stated that the patient did not report full body rash at the time, only reported the rash once the pharmacist called them for a reminder for dose two of their SHINGRIX vaccine.
Employee had her flu shot as part of the PMH flu vaccination program. Employee's are hurt for a couple days and then emplyee began to feel tingling in various parts of her face and just did not feel well. Employee went to her PCP and then when symptoms got worse PCP told her to go to ER which she did. ER confirmed Bell's Palsy.
I received my Covid-19 vaccine on 09/21/2022. I was diagnosed with Covid-19 on 11/29/2022. I woke up fine however late that afternoon I had a headache and was experiencing some brain fog. I also had a slight congestion and decided to take an at home Covid-19 test which determined I was positive for Covid-19. I tested negative on 12/18/2022 with only isolation and no medication only symptoms that persisted was irregular sleep patterns.
Systemic: Numbness (specify: facial area, extremities)-Mild, Additional Details: patient said she had numbness occure 2 hours after first shot. numbness in left neck,left chest,left arm,left shoulder
Rash on neck/Rash on neck, eyelids and around mouth; Rash on neck, eyelids; second dose in May of 2020 (>6months); This case was reported by a consumer via call center representative and described the occurrence of rash in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Hepatitis A vaccine for prophylaxis.   Previously administered products included Shingrix with an associated reaction of rash (On 2nd August 2019, 1st dose received. Please refer the case US2020092761).   On 2nd May 2020, the patient received the 2nd dose of Shingrix (intramuscular) and Hepatitis A vaccine. On 2nd May 2020, unknown after receiving Shingrix and not applicable after receiving Hepatitis A vaccine, the patient experienced drug dose administration interval too long. On an unknown date, the patient experienced rash and eyelid rash. On an unknown date, the outcome of the rash, eyelid rash and drug dose administration interval too long were unknown.   It was unknown if the reporter considered the rash and eyelid rash to be related to Shingrix and Hepatitis A vaccine.  Additional details were provided as follows: The patient received 1st dose on 2nd August 2019, and 2nd dose received on 2nd May 2020, which led to lengthening of the vaccination schedule. Less than a month after receiving the 2nd dose of Shingrix the patient experienced rash on her neck, eyelids and around her mouth. The patient was unsure which arm she received the Shingrix and which arm she received the Hepatitis A vaccine.  The reporter consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020092761:
Information has been received from a health professional concerning a 14 month old 20lb. 15oz. 29 in. female with no known pre-existing allergies, birth defects, or medical conditions, who on 03-MAR-2008 at 11:30 hrs was vaccinated with a first subcutaneous dose in the left thigh of VARIVAX (Merck) (lot# 659932/1790U). There was no reported illness at the time of vaccination. On 11-MAR-2008 at 16:00 hrs, the health professional indicated that the mother reported that the patient had developed a local reaction at the site described as redness, and a lump at the site on the left thigh. It was reported that the patient had hives on the back of right leg, and small areas on arms, and chest, but mostly on the right leg. On 17-MAR-2008, the patient had recovered. A product quality complaint was not reported. Additional information is not expected.
Lymph node to left Scilla swollen larger than a golf ball. Painful and tender to the touch. Feels like there?s fluid in the ?golf ball?. Fever of 103 which subsided. A very Stiff neck which has not gone away. Fatigue. Extreme anxiety. Red dots on my back. Chest pain which subsided. A headache that comes and goes. Chills which come and go. Tremors of my torso (couldn?t stop shaking for a few hours this started around 13 hours post-vaccination). Tremors subsided.